During the past decade, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator and "Janssen-Cilag Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia" are "Follicular Lymphoma" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Acute Lymphoid Leukemia" (1 trials), "Acute Myeloid Leukemia With FLT3/ITD Mutation" (1 trials) and "B-Cell Lymphomas" (1 trials). Many other conditions were trialed in "Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia" in a lesser frequency.

Most popular intervention types in "Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia" are "Drug" (14 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Venetoclax" (3 trials), "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".